Reports for TAKEDA CANADA INC

Company Name

TAKEDA CANADA INC

Totals

Shortage reports

52
Actual shortage: 1 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 51 (98%)

Discontinuation Reports

7
To be discontinued: 0 (0%)
Discontinued: 7 (100%)
Reversed: 0 (0%)

Late reports

0 (0%)

Overdue reports

0 (0%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MEZAVANT 1.2G TABLET (DELAYED AND EXTENDED RELEASE) Resolved 2022-10-14 2022-11-02 171844
VYVANSE 30MG CAPSULE Resolved 2022-12-19 2023-01-16 178913
VYVANSE 40MG TABLET (CHEWABLE) Resolved 2023-02-24 2023-03-07 185609
VYVANSE 20MG CAPSULE Resolved 2023-06-23 2023-10-07 196238
RIXUBIS 2000UNIT POWDER FOR SOLUTION KIT Resolved 2023-07-13 2023-08-28 198627
RIXUBIS 1000UNIT POWDER FOR SOLUTION KIT Resolved 2023-07-13 2023-08-28 198631
RIXUBIS 3000UNIT POWDER FOR SOLUTION KIT Resolved 2023-07-13 2023-08-28 198634
GAMMAGARD S/D 5G KIT SOLUTION POWDER FOR SOLUTION Resolved 2023-08-23 2023-09-14 202833
VYVANSE 10MG CAPSULE Resolved 2023-08-30 2023-09-14 203355
GAMMAGARD S/D 5G KIT SOLUTION POWDER FOR SOLUTION Resolved 2023-10-18 2024-01-31 207306
VYVANSE 10MG CAPSULE Resolved 2024-02-27 2024-03-18 220802
DEXILANT 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-03-22 2024-03-23 223152

Showing 41 to 52 of 52

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PANTO IV 40MG POWDER FOR SOLUTION Discontinued 2017-03-15 2017-03-15 2969
ACTOS 15MG TABLET Discontinued 2018-04-02 2018-04-02 44428
ACTOS 30MG TABLET Discontinued 2018-04-02 2018-04-02 44433
ACTOS 45MG TABLET Discontinued 2018-04-02 2018-04-02 44438
ULORIC 80MG TABLET Discontinued 2021-08-17 2022-01-04 144266
FOSRENOL 250MG TABLET (CHEWABLE) Discontinued 2022-12-20 2023-04-30 178916
AGRYLIN 0.5MG CAPSULE Discontinued 2023-11-15 2024-03-01 210182

Showing 1 to 7 of 7